Skip to main content
. 2018 Feb 19;8:3269. doi: 10.1038/s41598-018-21641-1

Figure 7.

Figure 7

Amyloid burden in mice injected with human brain extracts from distinct molecular profiles of Alzheimer’s disease. Mice inoculated with an Alzheimer brain homogenate from AP1 subgroup (ad), AP2 subgroup (eh), APPA713T (fAD2) (il), APPA673V (fAD1) (mp), sAD1 case (q–t) and control groups, i.e. age-matched noninjected mice (ux) and mice injected with Aβ-immunodepleted brain extracts (aa–dd). (a,e,i,m,q,u,aa) Amyloid deposits, scale bar 0,5 mm. (b,f,j,n,r,v,bb) Congophilic amyloid angiopathy, 300 µm. (c,g,k,o,s,w,cc) Intraneuronal Aβ immunoreactivity, scale bar 120 µm. (d,h,l,p,t,x,dd) Amyloid plaques, scale bar 120 um. Immunostaining with 4G8 antibody.